While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on the company, suggesting that sentiment on APRI is moving in the right direction. In fact, the stock currently has a Zacks Rank# 2 (Buy), suggesting that the recent run could certainly continue for this in-focus company.
APRICUS BIOSCIENCES INC (APRI): Free Stock Analysis Report
Zacks Investment Research
- Investment & Company Information